This indicates that SIRT1 upregulated V-ATPase activities to increase lysosomal function, which halted the secretion of exosomes containing hydrolases that degrade the extracellular matrix, thereby ultimately inhibiting the aggressiveness of MDA-MB-231 breast cancer cells. Here, SIRT1 is linked to breast carcinoma.